PAM
IGC icon

Panagora Asset Management’s IGC Pharma IGC Stock Holding History

Panagora Asset Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-76,561
Closed -$27K – 2322
2017
Q3 		$27K Sell
76,561
-16,793
-18% -$6.22K ﹤0.01% 2141
2017
Q2 		$38K Buy
93,354
+44,195
+90% +$19.7K ﹤0.01% 2129
2017
Q1 		$23K Hold
49,159
– – ﹤0.01% 2145
2016
Q4 		$14K Hold
49,159
– – ﹤0.01% 2268
2016
Q3 		$23K Buy
+49,159
New +$23.8K ﹤0.01% 2243

Other funds holding IGC

Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SB
Suntrust Banks Atlanta, Georgia $19.2B AUM 0.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Panagora Asset Management's IGC Position: Q4 2017 in Review

Panagora Asset Management sold out of IGC Pharma (IGC) in Q4 2017, closing a stake of 76,561 shares — an estimated $27K sold.

Panagora Asset Management first reported a position in IGC in Q3 2016 and held it in 5 quarters. The position peaked at $38K in Q2 2017. 7 funds tracked by Wall St. Rank hold IGC as of Q4 2017.

  • Panagora Asset Management reported no remaining IGC Pharma position as of Q4 2017 after selling out during the quarter.
  • Panagora Asset Management sold 76,561 IGC Pharma shares in Q4 2017, an estimated $27K.
  • Panagora Asset Management first reported a position in IGC Pharma in Q3 2016 and held it in 5 quarters.
  • Panagora Asset Management's IGC Pharma position peaked at $38K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2017.

Based on Panagora Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.